Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
Industry Insights
Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug
Teva and Royalty Pharma advance the autoimmune drug development through a Teva, Royalty Pharma $500M deal supporting vitiligo trials and later-stage studies.
Novartis and SciNeuro brain shuttle deal includes $165M upfront for an antibody program aimed at delivering Alzheimer's therapies across the blood-brain barrier
AstraZeneca-Modella AI Acquisition to Speed Oncology R&D
Upcoming AstraZeneca-Modella AI acquisition may bring AI models of Modella in-house to speed oncology research, biomarker discovery, clinical trial efficiency.
UK Clinical Trial Regulatory Reforms Aim to Boost Research
UK clinical trial regulatory reforms introduce faster approvals and new routes to improve research timelines and strengthen the UK’s appeal for medical studies.
Bayer-Attralus diagnostic tracers deal adds two experimental imaging agents, marking Bayer’s entry into tracer development for cardiac amyloidosis diagnosis.
